Synthesis and beta-adrenergic blocking activity of a novel class of aromatic oxime ethers.
作者信息
Leclerc G, Mann A, Wermuth C G, Bieth N, Schwartz J
出版信息
J Med Chem. 1977 Dec;20(12):1657-62. doi: 10.1021/jm00222a023.
PMID:22751
Abstract
A new series of beta-adrenergic blocking amines containing an oximino-propanolic chain linked to an aromatic nucleus was synthesized. Most of the derivatives are characterized by beta2-selectivity. The structure-activity relationship are discussed. One of the compounds, selected for further studies, was more active on the trachea than on the atria of guinea pig, 155 times in vitro and 26 times in vivo. In comparison, butoxamine's beta2-selectivity is 13 in vitro and only 2 in vivo. With a series of 30 acetophenone oxime derivatives, no quantitative structure-activity relationships could be detected.
摘要
相似文献
1
Synthesis and beta-adrenergic blocking activity of a novel class of aromatic oxime ethers.
J Med Chem. 1977 Dec;20(12):1657-62. doi: 10.1021/jm00222a023.
2
Synthesis and beta-adrenergic blocking activity of new aliphatic oxime ethers.
J Med Chem. 1980 Jun;23(6):620-4. doi: 10.1021/jm00180a007.
3
Synthesis and beta-adrenergic blocking activity of new aliphatic and alicyclic oxime ethers.
J Med Chem. 1984 Oct;27(10):1291-4. doi: 10.1021/jm00376a011.
4
Adrenoceptor blocking agents. 2. 2-(alpha-Hydroxyarylmethyl)-3,3-dimethylaziridines, a new class of selective beta2-adrenoceptor antagonists.肾上腺素能受体阻断剂。2. 2-（α-羟基芳基甲基）-3,3-二甲基氮丙啶，一类新型的选择性β2-肾上腺素能受体拮抗剂。
J Med Chem. 1978 Jan;21(1):68-72. doi: 10.1021/jm00199a012.
5
Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.心脏选择性β-肾上腺素能阻滞剂。1. 1-((3,4-二甲氧基苯乙基)氨基)-3 - 芳氧基-2-丙醇。
J Med Chem. 1975 Feb;18(2):148-52. doi: 10.1021/jm00236a007.
6
Synthesis and adrenergic activity of a new series of N-aryl dicyclopropyl ketone oxime ethers: SAR and stereochemical aspects.新型N-芳基二环丙基甲酮肟醚系列的合成与肾上腺素能活性：构效关系及立体化学方面
J Med Chem. 1998 May 7;41(10):1613-8. doi: 10.1021/jm970338c.
7
Beta-adrenoreceptor blocking heterocyclic oximes and ethers.β-肾上腺素能受体阻断杂环肟类和醚类化合物。
Farmaco. 1996 Nov;51(11):699-706.
8
Synthesis and irreversible beta-adrenergic blockade with a bromoacetamido derivative of betaxolol.倍他洛尔的溴乙酰胺衍生物的合成及不可逆β-肾上腺素能阻断作用
J Pharm Sci. 1985 Oct;74(10):1117-9. doi: 10.1002/jps.2600741024.
9
Synthesis and preliminary biological studies of 4- and 5-[2-hydroxy-3-(isopropylamino)propoxy]benzimidazoles: selective beta2 adrenergic blocking agents.4-和5-[2-羟基-3-(异丙基氨基)丙氧基]苯并咪唑的合成及初步生物学研究：选择性β2肾上腺素能阻滞剂
J Med Chem. 1979 Feb;22(2):210-4. doi: 10.1021/jm00188a019.
10
Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.新型潜在超短效β受体阻滞剂的合成与药理评价
Pharmazie. 2003 Jan;58(1):18-21.
引用本文的文献
1
Activation of carbonic anhydrases from human brain by amino alcohol oxime ethers: towards human carbonic anhydrase VII selective activators.通过氨基酸醇肟醚激活人脑碳酸酐酶：开发人类碳酸酐酶 VII 选择性激活剂。
J Enzyme Inhib Med Chem. 2021 Dec;36(1):48-57. doi: 10.1080/14756366.2020.1838501.
2
Synthesis, docking study and β-adrenoceptor activity of some new oxime ether derivatives.一些新型肟醚衍生物的合成、对接研究及β-肾上腺素能受体活性
Molecules. 2014 Mar 20;19(3):3417-35. doi: 10.3390/molecules19033417.
3
In vitro activity of RO363, a beta1-adrenoceptor selective agonist.β1肾上腺素能受体选择性激动剂RO363的体外活性
Br J Pharmacol. 1980 Apr;68(4):677-85. doi: 10.1111/j.1476-5381.1980.tb10860.x.
Zotero 插件